Author Archives: wpadmin

FDA Approves Rybelsus (semaglutide), the First Oral GLP-1 Analog Treatment for Adults with Type 2 Diabetes

FDA Approves Rybelsus (semaglutide), the First Oral GLP-1 Analog Treatment for Adults with Type 2 Diabetes Print this page PLAINSBORO, N.J., Sept. 20, 2019 /PRNewswire/ — Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved Rybelsus (semaglutide) tablets 7 mg or 14 mg for adults with type 2 diabetes that… Read More »

New Treatments and Declining Death Rate Lead to Rapid Rise in Cancer Survivors

Thanks in part to healthier lifestyles and investment in research that has yielded new treatments, cancer incidence (new cases) and mortality rates have fallen in recent decades. But the overall growth—and aging—of the United States and global populations contribute to a rising total number of people diagnosed with cancer as well as an increase in… Read More »